About Vesalius Cardiovascular
Vesalius Cardiovascular is a company based in Vancouver (Canada) founded in 2016.. Vesalius Cardiovascular has raised $1.89 million across 5 funding rounds. The company has 49 employees as of May 27, 2025. Vesalius Cardiovascular offers products and services including TMVr System. Vesalius Cardiovascular operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
- Headquarter Vancouver, Canada
- Employees 49 as on 27 May, 2025
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vesalius Cardiovascular Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.89 M (USD)
in 5 rounds
-
Latest Funding Round
$50.31 K (USD), Seed
Aug 15, 2025
-
Investors
-
Employee Count
49
as on May 27, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vesalius Cardiovascular
Vesalius Cardiovascular offers a comprehensive portfolio of products and services, including TMVr System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides catheter-based repair for degenerative mitral regurgitation.
Unlock access to complete
Unlock access to complete
Funding Insights of Vesalius Cardiovascular
Vesalius Cardiovascular has successfully raised a total of $1.89M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $50.31 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $50,308
-
First Round
First Round
(28 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Seed - Vesalius Cardiovascular | Valuation |
investors |
|
| Dec, 2024 | Amount | Seed - Vesalius Cardiovascular | Valuation |
investors |
|
| Nov, 2024 | Amount | Seed - Vesalius Cardiovascular | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Vesalius Cardiovascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vesalius Cardiovascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vesalius Cardiovascular Comparisons
Competitors of Vesalius Cardiovascular
Vesalius Cardiovascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Minimally invasive heart valve replacement devices are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vesalius Cardiovascular
Frequently Asked Questions about Vesalius Cardiovascular
When was Vesalius Cardiovascular founded?
Vesalius Cardiovascular was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Vesalius Cardiovascular located?
Vesalius Cardiovascular is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is Vesalius Cardiovascular a funded company?
Vesalius Cardiovascular is a funded company, having raised a total of $1.89M across 5 funding rounds to date. The company's 1st funding round was a Seed of $107.01K, raised on May 28, 2018.
How many employees does Vesalius Cardiovascular have?
As of May 27, 2025, the latest employee count at Vesalius Cardiovascular is 49.
What does Vesalius Cardiovascular do?
Vesalius Cardiovascular was founded in 2016 in Vancouver, Canada, within the biomedical sector. Devices such as Calla-TC3 and LAD are being developed to address degenerative mitral regurgitation from valve prolapse and functional mitral regurgitation from cardiomyopathy. These percutaneous devices are introduced into the heart to treat the conditions. Operations focus on cardiovascular device innovation for clinical applications.
Who are the top competitors of Vesalius Cardiovascular?
Vesalius Cardiovascular's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
What products or services does Vesalius Cardiovascular offer?
Vesalius Cardiovascular offers TMVr System.